5 completed, 4 recruiting, 1 terminated. 4 Phase 1, 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 3 | 4 | Recruiting 3, Completed 1 |
| Phase 2 | 2 | Completed 2 |
Follow PF-06741086: new trials by email Literature Review of PF-06741086 trials Research Report on PF-06741086
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Hemophilia A (9) · Hemophilia B (4) · Hemorrhage (2)
Pfizer (10)
United States (7) · South Africa (5) · China (4) · Croatia (4) · India (4) · Turkey (Türkiye) (4) · Brazil (3) · Canada (3) · Italy (3) · Japan (3) · South Korea (3) · Spain (3) · Taiwan (3) · Argentina (2) · Australia (2)
PMID 42698050, PMID 35999026, PMID 36220152, PMID 40608864, PMID 41351884
2015 (1), 2016 (1), 2017 (1), 2018 (1)